Bayer down after 'mixed reception' at U.S Supreme Court

Galderma AG

28/04/2026 07:19

** Shares in German pharmaceutical company Bayer BAYGn.DE are down 3.4% in early Frankfurt trade with a local trader pointing to a "mixed reception" at a U.S supreme court hearing

** On Monday, the U.S. supreme court appeared split on Bayer's appeal of a verdict in Missouri awarding $1.25 million to a plaintiff from complications related to Roundup weedkiller

** Up to the previous session's close, shares were up 3.7%​ YTD

 (Reporting by Cian Muenster)

 ((Cian.muenster@thomsonreuters.com))